Core Scientific, Inc. CORZ Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $115.24M+44.5% | $79.76M-1.7% | $81.1M+3.1% | $78.63M-1.1% | $79.53M-16.2% | ||
| $85.14M+44.3% | $59.01M-23.6% | $77.2M+4.9% | $73.6M+3.2% | $71.31M-20.9% | ||
| $30.11M+45.1% | $20.76M+431% | $3.91M-22.3% | $5.03M-38.8% | $8.21M+72.4% | ||
| 26.1%+0.1pp | 26%+21.2pp | 4.8%-1.6pp | 6.4%-3.9pp | 10.3%+5.3pp | ||
| $44.85M+6,874% | $643K-99.1% | $69.35M+21.8% | $56.94M+76.4% | $32.29M+29.0% | ||
| $266.49M— | —— | —— | —— | $0-100% | ||
| -$4.86M— | —— | $821K-30.7% | $1.19M-45.8% | $2.19M+293% | ||
| -$36.17M— | —— | -$89.11M+90.2% | -$910.36M-246% | $623.49M+377% | ||
| -$13.64M-430% | -$2.58M+12.2% | -$2.93M+29.6% | -$4.17M-69,333% | -$6K+96.0% | ||
| $600K+532% | $95K-24.0% | $125K-20.9% | $158K-22.9% | $205K-45.3% | ||
| -$347.19M— | —— | -$146.66M+84.3% | -$936.8M-263% | $576.25M+298% | ||
| -301.3%— | —— | -180.8%+1,011pp | -1,191.4%-1,916pp | 724.6%+1,031pp | ||
| -$1.06+41.1% | -$1.80-291% | -$0.46-1,050% | -$0.04-103% | $1.42+306% | ||
| 322.9M+1.5% | 318.1M-0.2% | 318.6M+0.2% | 318M-12.5% | 363.3M+42.0% | ||
| 322.9M+1.5% | 318.1M-0.2% | 318.6M+0.2% | 318M+0.9% | 315.2M+23.2% | ||
| -$6.56M+89.4% | -$61.67M-663% | $10.96M-63.2% | $29.8M+379% | -$10.69M-1,228% | ||
| -$500K— | —— | -$15.08M— | —— | $0— | ||
| $30.8M— | —— | $74.86M-91.8% | $909.96M+246% | -$621.46M-377% | ||
| -$4.86M— | —— | $821K-30.7% | $1.19M-45.8% | $2.19M+293% | ||
| $333K— | —— | —— | —— | $603K-50.0% | ||
| $8.67M— | —— | —— | —— | $11.67M+240% | ||
| -$13.64M-430% | -$2.58M+12.2% | -$2.93M+29.6% | -$4.17M-69,333% | -$6K+96.0% | ||
| $5.87M-79.3% | $28.4M+2,392% | -$1.24M+40.5% | -$2.08M+85.4% | -$14.3M-2,162% | ||
| -$16.36M+61.4% | -$42.34M-222% | $34.73M+378% | -$12.5M-561% | $2.71M-94.2% | ||
| $971.38M+4,554% | -$21.81M-310% | -$5.32M+83.2% | -$31.77M-657% | -$4.2M-101% | ||
| -$386.65M-41.5% | -$273.33M-7.5% | -$254.36M-105% | -$124.05M-39.4% | -$89.02M-209% | ||
| $249.88M+63.2% | $153.07M+16.2% | $131.78M+243% | $38.44M+185% | -$45.04M-426% | ||
| -$10K+91.1% | -$112K-1,500% | $8K+104% | -$207K-31.8% | -$157K-133% | ||
| $266.49M— | —— | —— | —— | $0-100% | ||
| -$293.77M-179% | -$105.19M-156% | -$41.1M-446% | -$7.53M+72.4% | -$27.31M+30.6% | ||
| -254.9%-123pp | -131.9%-81.2pp | -50.7%-41.1pp | -9.6%+24.8pp | -34.3%+7.1pp | ||
| -$310.42M-160% | -$119.28M-108% | -$57.43M-118% | -$26.28M+44.1% | -$47.04M+28.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Core Scientific, Inc.'s revenue?
- Core Scientific, Inc. (CORZ) generated $354.7M in revenue over the trailing twelve months, down 13.7% year over year.
- Is Core Scientific, Inc. profitable?
- Core Scientific, Inc. is not currently profitable: it reported a net loss of $854.4M over the trailing twelve months, a -238.9% net margin.
- What are Core Scientific, Inc.'s profit margins?
- Gross margin is 16.9% and operating margin is -144.7%, with a -238.9% net margin.
- What is Core Scientific, Inc.'s earnings per share?
- Core Scientific, Inc.'s diluted EPS over the trailing twelve months is $-3.18.
- Where does Core Scientific, Inc.'s income statement data come from?
- Every line is extracted from Core Scientific, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
